Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Chest. 2018 Jul 17;154(6):1301–1310. doi: 10.1016/j.chest.2018.07.002

Table 2:

Bronchodilator pulmonary function test results

Variable Asthma COPD
overlap,
mean ± SD
Isolated-asthma,
mean ± SD
Isolated-COPD,
mean ± SD
Neither diagnosis,
mean ± SD
 Pre-BDa FEV1b % predicted 67.3±14.8 80.9±13.5f 82.3±15.2f 96.9±13.2f
 Post-BD FEV1 % predicted 81.3±14.5 96.2±13.7f 85.9±15.0f 100.5±13.5f
Pre-BD FVCc % predicted 93.3±15.8 87.1±13.9f 101.2±15.1f 98.3±12.9f
 Post-BD FVC % predicted 101.8±14.0 96.0±13.3f 103.4±15.1 98.5±12.9f
 Pre-BD FEV1/FVC 0.56±0.08 0.73±0.07f 0.62±0.07f 0.77±0.05f
Post-BD FEV1/FVC 0.62±0.07 0.78±0.05f 0.64±0.06f 0.80±0.05f
Pre-BD RVd/TLCe 0.40±0.10 0.33±0.09f 0.33±0.08f 0.28±0.07f
a

Bronchodilator

b

Forced expiratory volume in one second

c

Forced vital capacity

d

Residual volume

e

Total lung capacity

f

p<0.05 vs. Asthma/COPD overlap subgroup